Design of neo‐glycoconjugates that target the mannose receptor and enhance TLR‐independent cross‐presentation and Th1 polarization
Satwinder Singh(Central University of Punjab), Yvette van Kooyk(Amsterdam University Medical Centers), Manja Litjens(Utrecht University), Hakan Kalay(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ingeborg Streng‐Ouwehand(Amsterdam UMC Location Vrije Universiteit Amsterdam), Christian Kurts(University Hospital Bonn), Wendy W. J. Unger(Erasmus MC), Sven Burgdorf(University of Bonn), Eiríkur Saeland(Janssen (Netherlands))
Cited by 56
Related Papers
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB
|Immunity|2007|573
Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk
|Nature Immunology|2009|482
The tumour glyco-code as a novel immune checkpoint for immunotherapy
|Nature reviews. Immunology|2018|470